Current and historical daily PE Ratio for Beximco Pharmaceuticals Ltd (
) from 2005 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beximco Pharmaceuticals stock (LSE:BXP) PE ratio as of Jun 20 2024 is 12.74.
More Details
Beximco Pharmaceuticals Ltd (LSE:BXP) PE Ratio (TTM) Chart
Beximco Pharmaceuticals Ltd (LSE:BXP) PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Total 1281
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Beximco Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-20 | 6.9 | 2024-04-16 | 6.4 |
| 2024-06-19 | 6.9 | 2024-04-15 | 6.4 |
| 2024-06-18 | 6.8 | 2024-04-12 | 6.4 |
| 2024-06-17 | 6.8 | 2024-04-11 | 6.4 |
| 2024-06-14 | 6.8 | 2024-04-10 | 6.4 |
| 2024-06-13 | 6.8 | 2024-04-09 | 6.4 |
| 2024-06-12 | 6.8 | 2024-04-08 | 6.4 |
| 2024-06-11 | 6.8 | 2024-04-05 | 6.4 |
| 2024-06-10 | 6.8 | 2024-04-04 | 6.6 |
| 2024-06-07 | 6.8 | 2024-04-03 | 6.6 |
| 2024-06-06 | 6.8 | 2024-04-02 | 6.6 |
| 2024-06-05 | 6.8 | 2024-04-01 | 6.8 |
| 2024-06-04 | 6.8 | 2024-03-29 | 6.8 |
| 2024-06-03 | 6.8 | 2024-03-28 | 6.8 |
| 2024-05-31 | 6.8 | 2024-03-27 | 7.5 |
| 2024-05-30 | 6.8 | 2024-03-26 | 7.6 |
| 2024-05-29 | 7.0 | 2024-03-25 | 7.6 |
| 2024-05-28 | 7.2 | 2024-03-22 | 7.4 |
| 2024-05-24 | 7.1 | 2024-03-21 | 7.4 |
| 2024-05-23 | 7.1 | 2024-03-20 | 7.4 |
| 2024-05-22 | 7.1 | 2024-03-19 | 7.4 |
| 2024-05-21 | 7.1 | 2024-03-18 | 7.4 |
| 2024-05-20 | 7.1 | 2024-03-15 | 7.4 |
| 2024-05-17 | 7.1 | 2024-03-14 | 7.2 |
| 2024-05-16 | 7.1 | 2024-03-13 | 7.5 |
| 2024-05-15 | 7.1 | 2024-03-12 | 7.7 |
| 2024-05-14 | 7.1 | 2024-03-11 | 7.7 |
| 2024-05-13 | 7.2 | 2024-03-08 | 7.8 |
| 2024-05-10 | 6.8 | 2024-03-07 | 7.8 |
| 2024-05-09 | 6.7 | 2024-03-06 | 7.8 |
| 2024-05-08 | 6.6 | 2024-03-05 | 7.8 |
| 2024-05-07 | 6.6 | 2024-03-04 | 7.8 |
| 2024-05-03 | 6.6 | 2024-03-01 | 7.8 |
| 2024-05-02 | 6.4 | 2024-02-29 | 7.8 |
| 2024-05-01 | 6.4 | 2024-02-28 | 7.8 |
| 2024-04-30 | 6.4 | 2024-02-27 | 7.8 |
| 2024-04-29 | 6.4 | 2024-02-26 | 7.8 |
| 2024-04-26 | 6.4 | 2024-02-23 | 7.8 |
| 2024-04-25 | 6.4 | 2024-02-22 | 7.8 |
| 2024-04-24 | 6.4 | 2024-02-21 | 7.9 |
| 2024-04-23 | 6.5 | 2024-02-20 | 7.7 |
| 2024-04-22 | 6.5 | 2024-02-19 | 7.7 |
| 2024-04-19 | 6.5 | 2024-02-16 | 7.7 |
| 2024-04-18 | 6.4 | 2024-02-15 | 7.7 |
| 2024-04-17 | 6.4 | 2024-02-14 | 7.6 |
Beximco Pharmaceuticals Ltd (LSE:BXP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beximco Pharmaceuticals Ltd
ISIN : US0885792061
Share Class Description:
LSE:BXP: DRCompare
Compare
Traded in other countries / regions
BXPHARMA.BangladeshBXP.UKR2WA.Germany IPO Date
2005-10-21Description
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers